Editor-in-Chief:

Ignacio Anegon
INSERM Unit 643
CHU Hôtel Dieu
30, boulevard Jean Monnet
44093 Nantes
France

Founding Editor:

Pedro R. Lowenstein
Gene Therapeutics Research Institute
Los Angeles, CA
USA

Associate Editors:

P. Aebischer (EPFL, Lausanne, Switzerland)
I.E. Alexander (New Children Hospital, Parramatta, NSW, Australia)
M.G. Castro (University of Michigan Medical School, Ann Arbor, MI, USA)
L.-J. Chang (University of Florida, Gainesville, FL, USA)
J.-P. Concordet (CNRS, Paris, France)
P. Cruz (Inst. de Biologia Experimental e Tecnol. Oeiras, Portugal)
D.T. Curiel (University of Alabama, Birmingham, AB, USA)
R.J. Festenstein (Imperial College London, London, UK)
C. Fillat (Centre de Regulació Genòmica, Barcelona, Spain)
C. Giovannangeli (CNRS, Paris, France)
J. Glorioso (University of Pittsburgh, Pittsburgh, PA, USA)
H.J. Haisma (University of Groningen, Groningen, The Netherlands)
R.G. Hawley (George Washington Univ. Med. Ctr., Washington, DC, USA)
Y.-C. Hu (National Tsing Hua University, Hsinchu, Taiwan)
F. Mavilio (University of Modena, Modena, Italy)
P. Moullier (INSERM U649, Nantes, France)
B. Pitard (INSERM, U915, Nantes, France)
F. Rolling (INSERM U649, Nantes, France)
M.-P. Rols (IPBS-CNRS, Toulouse, France)
M.G. Roncarolo (San Raffaele Telethon Inst. for Gene Therapy, Milan, Italy)
M. Tangney (Cork Cancer Research Centre, Cork, Ireland)
J. Verhaagen (Netherlands Inst. for Brain Res., Amsterdam, The Netherlands)
J.M. Wilson (University of Pennsylvania, Philadelphia, PA, USA)
F. Yao (Brigham and Women's Hospital, Boston, MA, USA)

Editorial Advisory Board:

A. Amalfitano (Duke University Medical Center, Durham, NC, USA)
J.M. Aran (Molecular Genetics Center-IRO, Barcelona, Spain)
P. Arbuthnot (Haematology University of the Witwatersrand, Wits, South Africa)
P.M. Cannon (University of Southern California, Los Angeles, CA, USA)
M.J.T. Carrondo (Inst. de Biologia Experimental e Tecnol., Oeiras, Portugal)
S.H. Cheng (Genzyme Corporation, Framingham, MA, USA)
J.A. Chiorini (National Institutes of Health, Bethesda, MD, USA)
O. Cohen-Hagenauer (National university of Cachan, Cachan Cedex, France)
S.L. Eck (Pfizer, Inc., Ann Arbor, MI, USA)
D.L. Ennist (DLE Consulting, Bethesda, MD, USA)
A.L. Epstein (Université Claude Bernard, Villeurbanne, France)
Y. Feng (Brigham and Women's Hospital, Boston, MA, USA)
T.R. Flotte (University of Florida, Gainesville, FL, USA)
R.E. Hawkins (Christie Hospital NHS Trust, Manchester, UK)
R. W. Herzog (University of Florida, Gainesville, FL, USA)
Z. Ivics (Max Delbruck Center for Molecular Medicine, Berlin, Germany)
A. Kalergis (Pontificia Universidad Católica de Chile, Santiago de Chile, Chile)
J. Kaplan (Genzyme Corporation, Framingham, MA, USA)
P.D. Kessler (Genvec, Inc., Gaithesburg, MD, USA)
I. Kovesdi (KILA Consultants, Rockville, MD, USA)
J. Lozier (FDA Ctr. for Biologics Evaluation & Res., Rockville, MD, USA)
G. Martino (San Raffaele Hospital, Milan, Italy)
R. Morishita (Osaka University Medical School, Osaka, Japan)
D.A. Muruve (University of Calgary, Calgary, AB, Canada)
J. Prieto (CIMA University of Navarra, Pamplona, Spain)
D.W. Russell (University of Washington, Seattle, WA, USA)
M. Sadelain (Mem. Sloan-Kettering Cancer Center, New York, NY, USA)
M. Schmidt (Nationales Zentrum für Tumorerkrankungen (NCT), Heidelberg, Germany)
S.K. Singh (Centre for Cellular Molecular Biology, Hyderabad, India)
R.O. Snyder (University of Florida, Gainesville, FL, USA)
A.W. Thomson (University of Pittsburgh, Pittsburgh, PA, USA)
M.J. Tiera (UNESP-Instituto de Biociências Letras e Ciências Exatas Av., SP, Brazil)
T. Vandendriessche (Interuniv. Inst. for Biotech., Leuven, Belgium)
S. Ylä-Herttuala (University of Kuopio, Kuopio, Finland)